Zobrazeno 1 - 10
of 110
pro vyhledávání: '"Eric Wenzler"'
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-11 (2024)
Abstract Background To evaluate the clearance of edoxaban during modeled in vitro continuous renal replacement therapy (CRRT), assess protein binding and circuit adsorption, and provide initial dosing recommendations. Methods Edoxaban was added to th
Externí odkaz:
https://doaj.org/article/c04e2c19f6b448a9ab19f434aae3e58b
Autor:
Luke S. P. Moore, Maria Virginia Villegas, Eric Wenzler, Timothy M. Rawson, Rita O. Oladele, Yohei Doi, Anucha Apisarnthanarak
Publikováno v:
Infectious Diseases and Therapy, Vol 12, Iss 6, Pp 1445-1463 (2023)
Abstract Despite technological advancements in infectious disease rapid diagnostic tests (RDTs) and use to direct therapy at the per-patient level, RDT utilisation in antimicrobial stewardship programmes (ASPs) is variable across low-to-middle income
Externí odkaz:
https://doaj.org/article/64c0e6c241b74b5c8c7276ebb77c0fd6
Autor:
Eric Wenzler, Alina Adeel, Tiffany Wu, Michele Jurkovic, Jeremy Walder, Emily Ramasra, Maureen Campion, Jan Cerny, Nicole M. Theodoropoulos
Publikováno v:
Infectious Disease Reports, Vol 13, Iss 3, Pp 843-854 (2021)
Background: Vancomycin-resistant Enterococcus faecium (VRE) in particular has evolved as an important cause of hospital acquired infection, especially in immunocompromised hosts. Methods: We present a complex case of a patient with relapsed acute mye
Externí odkaz:
https://doaj.org/article/12399db0ddfc46fd9f9f636e3fe82cc4
Autor:
Sarah M Michienzi, Mikayla Johnson, Thomas D Chiampas, Eric Wenzler, Rodrigo M Burgos, Renata O Smith, Melissa E Badowski
Publikováno v:
Drugs in Context, Vol 10, Pp 1-6 (2021)
Although tenofovir disoproxil fumarate (TDF) and tenofovir alafenamide (TAF) have been evaluated in various clinical trials, limited safety and efficacy data exist in real-world settings. The goal of this retrospective analysis is to assess changes i
Externí odkaz:
https://doaj.org/article/59c8178f2e7c4937891fdf0c3583f0cc
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
A deep understanding of an antimicrobial’s critical pharmacokinetic and pharmacodynamic properties is crucial towards optimizing its use in patients and bolstering the drug development program. With the growing threat of antimicrobial resistance an
Externí odkaz:
https://doaj.org/article/2d2f68921dd640a293cc59da1a4cacc9
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 3 (2022)
ABSTRACT Tetracycline-based combinations are increasingly used for serious carbapenem-nonsusceptible Acinetobacter baumannii (CNSAb) infections given their potent in vitro activity, synergism with other agents, and acceptable toxicity profile. Omadac
Externí odkaz:
https://doaj.org/article/685d9d92ed6644e3ba548123e824a652
Publikováno v:
BMC Nephrology, Vol 22, Iss 1, Pp 1-12 (2021)
Abstract Background To evaluate the transmembrane clearance (CLTM) of apixaban during modeled in vitro continuous renal replacement therapy (CRRT), assess protein binding and circuit adsorption, and provide initial dosing recommendations. Methods Api
Externí odkaz:
https://doaj.org/article/5354b0df78d14dc7bac24491c947526b
Autor:
Eric Wenzler, Patrick J. Scoble
Publikováno v:
Infectious Diseases and Therapy, Vol 9, Iss 4, Pp 769-784 (2020)
Plain Language Summary Carbapenem-resistant gram-negative pathogens, specifically, Enterobacteriaceae, remain an urgent public health threat, and safe, effective treatment options are limited. The antibiotic agents meropenem and vaborbactam were sele
Externí odkaz:
https://doaj.org/article/63926c15fcd848c5a45f8604cabdaa44
Autor:
Zackery P. Bulman, Fiorella Krapp, Nathan B. Pincus, Eric Wenzler, Katherine R. Murphy, Chao Qi, Egon A. Ozer, Alan R. Hauser
Publikováno v:
mSystems, Vol 6, Iss 5 (2021)
ABSTRACT Carbapenem-resistant Klebsiella pneumoniae strains cause severe infections that are difficult to treat. The production of carbapenemases such as the K. pneumoniae carbapenemase (KPC) is a common mechanism by which these strains resist killin
Externí odkaz:
https://doaj.org/article/785657a5d69e48f983c300f7f8e48ba9
Publikováno v:
Thrombosis Update, Vol 4, Iss , Pp 100060- (2021)
Introduction: Heparin-induced thrombocytopenia (HIT) necessitates initiation of non-heparin based anticoagulation to prevent long-term sequelae. Optimal anticoagulation needs to be reached safely and rapidly. The optimal adjustment of argatroban dosi
Externí odkaz:
https://doaj.org/article/1299677d176f4c8383a293c4bc1b4b89